SNCA and Parkinson disease: Interestingly, this increase in α-synuclein was also positively correlated with the volume of inflammatory (MHC-II +) cells, indicating complex inter-relationships between α-synuclein upregulation, elevated inflammatory responses and dopaminergic loss that could contribute to the pathophysiology of PD development following injury [114].